最終更新日:2022/12/24
In addition, EPs 7630 was shown to be effective in clinical trials with patients suffering from tonsillopharyngitis, rhinosinusitis, common cold or COPD.
編集履歴(0)
In addition, EPs 7630 was shown to be effective in clinical trials with patients suffering from tonsillopharyngitis, rhinosinusitis, common cold or COPD.